Towards a framework for business model innovation in health care delivery in developing countries by unknown
Medicine for Global Health
Castano BMC Medicine 2014, 12:233
http://www.biomedcentral.com/1741-7015/12/233OPINION Open AccessTowards a framework for business model
innovation in health care delivery in developing
countries
Ramon CastanoAbstract
Background: Uncertainty and information asymmetries in health care are the basis for a supply-sided mindset in
the health care industry and for a business model for hospitals and doctor’s practices; these two models have to be
challenged with business model innovation. The three elements which ensure this are standardizability, separability,
and patient-centeredness. As scientific evidence advances and outcomes are more predictable, standardization
is more feasible. If a standardized process can also be separated from the hospital and doctor’s practice, it is
more likely that innovative business models emerge. Regarding patient centeredness, it has to go beyond the
oversimplifying approach to patient satisfaction with amenities and interpersonal skills of staff, to include the
design of structure and processes starting from patients’ needs, expectations, and preferences. Six business models
are proposed in this article, including those of hospitals and doctor’s practices.
Discussion: Unravelling standardized and separable processes from the traditional hospital setting will increase
hospital expenditure, however, the new business models would reduce expenses. The net effect on efficiency could
be argued to be positive. Regarding equity in access to high-quality care, most of the innovations described along
these business models have emerged in developing countries; it is therefore reasonable to be optimistic regarding
their impact on access by the poor. These models provide a promising route to achieve sustainable universal access
to high quality care by the poor.
Summary: Business model innovation is a necessary step to guarantee sustainability of health care systems;
standardizability, separability, and patient-centeredness are key elements underlying the six business model innovations
proposed in this article.
Keywords: Business model innovation, Quality care, Standardization, Separability, Patient-centerednessBackground
Health care systems face a growing pressure to meet peo-
ple’s needs with limited resources. The pressure grows,
among other reasons, as a consequence of demographic
and epidemiologic transitions, but mostly as a conse-
quence of new medical technologies that generate small
incremental benefits at high incremental costs [1]. This
begs the question, why is it that health care technologies
increase costs instead of the opposite, as is the case in
other industries? Several authors have proposed that
health systems should create more value for money [2] or
that they should have a triple aim of better health, betterCorrespondence: ramonabel@yahoo.com
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unless otherwise stated.care, and lower costs [3]. Thus, why do these undisputable
goals prove so elusive and health expenditures continue to
grow apparently irrespective of value creation? What are
the root causes of this apparently uncontrollable problem
of sustainability?
The root causes of the problem of sustainability
In a seminal paper in health economics, Kenneth Arrow
proposed that uncertainty in the diagnosis and treatment
of disease makes it difficult for doctors and hospitals to
achieve predictable outcomes [4]. In addition, large in-
formation asymmetries between doctors and patients
make it difficult for the latter to drive quality improve-
ments and innovations that yield more value for less
money [4]. On the other hand, those societies thatThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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willingness or ability to pay from the actual medical care
received. This creates a moral hazard problem whereby
the marginal benefit of care is far lower than its marginal
cost. As a consequence of uncertainty and information
asymmetry, non-market institutions emerge to control
the potential agency problems that markets or govern-
ment regulations cannot control by themselves. Profes-
sionalism, not-for-profit status of hospitals, prohibition
of advertising and price competition, and lack of an obli-
gation to guarantee good outcomes, are at the heart of
medical care values, according to Arrow [4].
These values might seem obvious to people within the
health care industry. However, contrasting this industry
with others where uncertainty and information asym-
metry are not that large, sheds some light about the
fundamental problems of current health care systems.
Although uncertainty and information asymmetries al-
ways exist, it is clear that in markets such as, e.g., per-
sonal computers or mobile phones, consumers have
enough information and certainty to make choices based
on their preferences and willingness to pay and net of
risks. Value for money is the driver of competition, qual-
ity improvements and innovation, and producers are
pushed every day to create new products that yield more
value at lower prices. Just think of the price you paid for
a laptop computer 10 years ago and its performance as
compared to your current computer.
In health care, value is not so obvious to patients. Al-
though every patient wants to have better quality of life
and better functional capacity (broadly addressed through
the increasingly used concept of patient-reported out-
comes), it is less obvious how the patient would assess the
short-term clinical outcomes that yield those benefits.
Hence the doctor’s role as an agent for the patient, in
order to fill the information gaps. As a consequence, doc-
tors and health care providers have been the traditional
designers of solutions to patients, which gives them the
privilege to create the structures and processes that,
provided good compliance to clinical practice, are ex-
pected to result in the best possible outcomes. However,
patients themselves are isolated from such design, ex-
cept for those quality attributes that are observable for
them, such as amenities and staff interpersonal skills.
This role of doctors and providers as designers of solu-
tions gives them a supply-sided mindset. In other indus-
tries that are driven by consumers’ search for value for
money, the design of value propositions starts from
consumers’ needs, expectations, and preferences, i.e.,
producers have a consumer-driven mindset. Perhaps
this is the most basic difference that, based on Arrow’s
powerful insights [4], explains why the health care in-
dustry lags behind other industries in creating more
value for each dollar spent.However, doctors and providers do not deliberately ig-
nore that creating value for patients is a paramount goal
for their day to day work. The problem lies in how value
is defined. Value in health care should be defined as bet-
ter outcomes for each dollar spent, and outcomes should
be defined around patients, not just around compliance
with processes, or around a number of services provided
or a simplistic view of patient satisfaction [2]. This begs
the question, why is it not possible for doctors and
health care providers to guarantee better outcomes to
such an extent that value-based competition works the
way it does in other industries? According to Christen-
sen et al. [5], another fundamental reason, rooted in the
same dysfunctionalities described by Arrow, is the busi-
ness model of hospitals and doctors’ practices. The au-
thors point to the fact that these two business models
are adequate to deal with uncertainty, but when uncer-
tainty is reduced and outcomes become more predict-
able, different business models must be developed to
exploit the advantages of standardization and task shift-
ing [5]. During the early twentieth century, when these
two business models (as we know them today) first
emerged, most health care was uncertain. The general
hospital and the doctor’s practice were adequate to the
nature of the task because they allowed for a wide array
of resources and capabilities to deal with the multiple
contingencies that are typical of uncertain processes.
However, to the extent that scientific evidence improves
and outcomes become more predictable, uncertainty is
reduced for some health care services. Consequently, the
better the evidence, the more predictable the outcomes,
and the more likely it will be to streamline the structures
and processes that are necessary for these types of ser-
vices. Streamlining means standardization of processes,
and once standardized, those processes can in many in-
stances be delegated to other staff. It is worth noting
that standardization by itself does not assure the wide-
spread adoption of the standard, a problem reported by
McGlynn et al. [6].
According to Christensen et al. [5], a major stumbling
block in the road to more value for money is that general
hospitals and doctor’s practices mix both standardized and
non-standardized processes in the same business model.
If standardized processes can be separated from non-
standardized ones, the former can be organized in more
efficient ways and outcomes will improve because of their
high predictability. To the extent that these processes are
kept together with non-standardized processes, the vari-
ability and uncertainty of the latter will affect the predict-
ability of the standardized processes. It appears then, that
the structure of health care delivery is at the root of
the problems most health care systems face. It is not that
doctors and health care providers are incompetent or de-
liberately poor performers. Rather, it is the business
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ged. This claim has been summarized by Ashish Jha, who
says that “…we deliver 21st century medicine using 19th
century practices” [7]. Porter and Teisberg point that “…
the structure of health care delivery is the most fundamental
issue” [2]. Christensen et al. claim that “The lack of business
model innovation in the health-care industry—in many
cases because regulators have not permitted it—is the reason
health care is unaffordable” [5]. Moreover, McGlynn et al.’s
claims regarding unacceptably low rates of adoption of stan-
dards, can be interpreted as symptoms of the structural
flaws of the prevailing business models [6].
Many commentators have argued that the problem lies
in how doctors and health care providers are paid. Fee-
for-service reimbursement creates incentives for demand
inducement, and no incentives to achieve better out-
comes through care coordination across the entire cycle
of care of a given medical condition. The lack of incen-
tives for coordination leads to severe fragmentation of
care, which makes it impossible for any provider to be
accountable for outcomes when these require coordin-
ation among several providers. The quick reaction to the
bad consequences of fee-for-service has been to shift to-
wards prospective payment modalities that transfer risk
to providers, on the expectation that this will create the
incentives to avoid demand inducement and to improve
coordination of care.
However, when doctors and providers switch from
retrospective to prospective payments but do not change
their business models, the perverse incentives associated
with fee-for-service (demand inducement, lack of coord-
ination) are replaced with the perverse incentives associ-
ated with capitation (cost shifting, skimping on care, and
cream skimming). In health systems where providers
compete for patients or for contracts with payers, and in
the absence of business model changes, both retrospect-
ive and prospective payments lead to value destruction
at both the provider and the payer level. In health sys-
tems without competition and lack of business model
changes, value destruction also ensues as a consequence
of how providers are paid or how they receive their oper-
ating budgets. Therefore, payment mechanisms by them-
selves do not create enough incentives to increase value. A
more fundamental change has to take place: a radical
change in business model.
Key elements for business model innovation
It could be argued that standardizability is an important
element enabling innovations in business models followed
by separability from hospital, and, finally, patient-centered
innovation.
Standardizability depends on knowledge about how a
process can be structured to achieve an outcome with
minimal uncertainty. Therefore, the stronger the scientificevidence explaining how A causes B, the more likely the
process will be standardized: the best way to make sure
that the expected outcome (B) is achieved, is making sure
the process (A) is strictly followed [8]. Standardization is a
necessary condition for task-shifting. A complex task that
is surrounded by uncertainty requires judgment based on
expertise and experience. Therefore, it has to be per-
formed by a highly skilled worker. In the opposite sense, a
simple task with little or no uncertainty requires little
judgment and can be written in a protocol, which can be
delegated to a less skilled worker. The most extreme case
of delegation is an automatic task that is delegated to a
computer or a machine. A good example of an entire
process that has been standardized, and therefore dele-
gated, is the application of an immunization schedule for a
baby. However necessary, standardization is not a sufficient
condition for delegation. Not all that is standardizable can
be delegated to less skilled workers. For example, placing a
stent in a coronary artery or performing a total hip replace-
ment requires a learning process that cannot be leap-
frogged by learning a protocol.
Separability is the principle whereby a given process
does not depend on a wide array of equipment, supplies,
and workforce, and can be set up in a separate facility
with dedicated resources that can be efficiently used,
i.e., with little or no idle capacity. Interdependencies in
hospital-based processes are typical of complex patients,
which makes these processes less separable. For example,
a given patient with metastatic lung cancer will require
many diagnostic and therapeutic processes and surgical
and non-surgical procedures, all requiring a wide variety
of specialties, equipment, and consumables. Another pa-
tient with the same type of cancer might need a different
mix of inputs, depending on the particular characteristics
of that patient. Therefore, interdependencies make it very
difficult to separate care for patients with metastatic lung
cancer in a freestanding facility.
A process of care that is highly standardized and
highly separable from a hospital or a doctor’s practice is
more likely to be arranged in an innovative business
model that widely differs from these two traditional
business models. Examples of this are cataract surgery
or hernia repair, as performed at Aravind Eye Care Sys-
tem [9] and Shouldice Hospital [10], respectively. Never-
theless, these two models have been on stage for several
decades, which hardly makes them innovative. The inter-
esting question is why they are not more pervasive in
health care systems. One business model that is enabled
by both standardizability and separability is that of spe-
cialized community health workers. In this model, lay
people apply highly standardized protocols for following
up patients in post-acute phase and patients with chronic
conditions in their community setting. Community workers
do not make clinical decisions; they are supervised by




Standardized Block 1 Block 2 Block 3
Non-standardized Block 4 Block 5 Block 6
Source: author’s creation.
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them as their “extensors” [11]. Nonetheless, non-
standardizable and non-separable processes can also be
reshaped with innovative business models as will be shown
below. This means that business model innovation is also
possible within the current hospital and doctor’s practice
models.
The third key element for innovation is patient cen-
teredness, or more broadly, person centeredness. As said
above, the supply-side mindset of health care providers
makes it difficult for them to understand patients’ needs,
expectations, and preferences, and to see them as oppor-
tunities for innovation. The farthest that most providers
go into this realm is to focus on patient satisfaction
with facilities and interpersonal skills of staff. How-
ever, patient-centeredness goes far beyond this oversim-
plifying approach. A case in point is care for rheumatoid
arthritis. Two therapeutic goals are key in caring for
these patients: prevention of structural damage and con-
trol of symptoms; abrogation of inflammation achieves
these two goals [12]. According to the author’s own un-
published research in Bogota, Colombia, from many
doctors’ perspective, it is enough to see the patient every
one to three months to keep track of levels of disease ac-
tivity. However, when a patient has a flare, she wants to
see the doctor immediately. However, the typical busi-
ness model of an ambulatory care center is not adequate
to deal with non-scheduled visits, and to deal with the
processes and activities required for the short-term man-
agement of flares. Therefore, patients must attend an
emergency room or visit another doctor, with the conse-
quent fragmentation of the cycle of care and coordin-
ation problems. Managing short-term symptoms is
much more important from the patient perspective than
from the doctor’s. However, a business model that is de-
signed from the doctor’s perspective to achieve long-
term goals does not meet patient needs, expectations,
and preferences in the short term.
This case illustrates the gap between a supply-sided
mindset and what consumers need, expect, or prefer. It
does not matter how well the staff treats the patient in
terms of interpersonal manners or how sympathetic they
are to patient complaints. It does not matter how con-
venient the facility is designed in terms of physical ac-
cess, waiting rooms, and amenities. The real problem
is that the whole business model has to be redesigned
to be able to deal with how the patient experiences ill-
ness. The traditional supply-sided mindset of doctors
and health care providers is, in fact, a tremendous op-
portunity for business model innovation, as illustrated
with the rheumatoid arthritis case. Most other industries
have become very sophisticated in anticipating consumer’s
needs, expectations, and preferences in order to come up
with new value propositions to win the race for consumervotes. This head-to-head race has led to repeated disrup-
tions that have yielded much better products and services
at lower prices. Health care lags far behind those indus-
tries, so the opportunities for innovation are immense,
just by turning back to patients and understanding their
needs, expectations, and preferences in a much deeper
way than the oversimplifying traditional approach to pa-
tient satisfaction.
Six business models instead of one
The process of care can be simplified into three steps: diag-
nosis, treatment, and self-care/self-management. Each of
these steps has both standardized and non-standardized com-
ponents. A simple way to understand how standardizable
and non-standardizable processes allow for innovation in
health care delivery models is to depict them as six separ-
ate building blocks that can be rearranged in different pat-
terns. Table 1 illustrates this framework. These six blocks
are mixed in the current business models of hospitals and
doctors’ practices, which is partly the source of their dys-
functionality, as shown above.
The framework in Table 1 allows for six separate cat-
egories, each with its own business models, as follows:
– Medical conditions for which diagnosis and
treatment are highly standardized (blocks 1 and 2).
This category includes, for example, diarrhea, minor
sunburns, athlete’s foot, etc. These conditions are
currently the focus of retail clinics in the United
States [13] and telephone assistance business
models. In these two models, the process of care is
standardized, can be delegated to non-physicians,
and operates outside hospitals and doctors’ practices.
The business model of community health workers
cited above is another example of this category.
– Medical or surgical treatments that are highly
standardized such as hernia repairs, cataract surgery,
or kidney transplantation (block 2). In this category,
some or all activities are highly standardized, and
some of the most standardized ones are delegated to
non-physicians [9]. Although cataract surgery and
hernia repairs are highly separable from general
hospitals, kidney transplantation is not separable,
particularly the surgical procedure. The high level of
standardization of these processes has deserved
them the name “focused factories” [14]. When the
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the figure of “a hospital within a hospital” allows
for keeping interdependencies while avoiding the
interference of non-standardized processes [8].
– Diagnostic processes (block 4). In this category, the
idea is to separate the diagnostic process from the
treatment decision. This separation aims to avoid
the framing bias that makes it more likely that a
doctor interprets signs and symptoms through the
lens of those medical conditions he or she knows
how to treat, or is familiar with. Although it could
be argued that a diagnostic algorithm is in fact a
standardized process, it is clear that, for a given
patient, it cannot be anticipated which of the
diagnostic possibilities she has, until the process of
hypothesis testing advances through the algorithm.
To avoid framing bias, the diagnostic process should
be performed in an interdisciplinary way and an
explicit process has to be put in place to force
clinicians to share their perspectives before making a
decision about diagnosis.
– Self-care and self-management (blocks 3 and 6). This
category includes many processes that are highly
standardized, such as taking medications, applying
non-pharmacological therapies, changing habits, and
adopting healthy lifestyles. Other processes, such as
responding to the particular psychological or social
needs of a given patient, are not standardizable. Both
processes can be dealt with more effectively through
peer-support communities [15]. Christensen et al.
propose the business model of facilitated networks:
web-based or real groups of people that share
common interests [5]. In this case, the common
interest is a medical condition, and the network
members support themselves to reinforce positive
behaviors and discourage negative ones. The classic
example of this category is Alcoholics Anonymous,
but modern-time facilitated networks have become
pervasive thanks to the internet [5].
– Integrated care of medical conditions (blocks 1, 2, 4,
and 5). This category derives from Porter and
Teisberg’s proposition of Integrated Practice Units,
which are meant to create value around medical
conditions, covering the complete cycle of care,
including comorbidities [2]. In this category,
standardized and non-standardized processes are
mixed, but focused on a given medical condition
or set of co-occurring conditions. However, risk
stratification of patients typically shows that a big
share of patients with a given condition are highly
to moderately standardizable and their outcomes
relatively predictable, while a minor share are
more complex and non-standardizable. Chronic
conditions, such as diabetes, heart failure, or chronicobstructive pulmonary disease, are more likely to
benefit from this business model.
– Non-standardized processes of diagnosis and
treatment (blocks 4 and 5). These are the typical
processes that made the bulk of the workload at
hospitals and doctors’ practices, when most health
care was highly uncertain because of a lack of
evidence. As scientific evidence allows for better
predictability of outcomes in some areas of health
care, standardization is more likely to be achieved.
If standardized processes of care can also be
separated from hospitals and doctors’ practices,
these latter two business models will end up
focusing on non-standardized, non-separable
processes. It is obvious that these two pillars of
health care delivery will not disappear, but it could
be argued that their business models will be
reshaped and their strategic focus will shift from
“everything-to-everybody” to a narrower focus on
those processes of care that exhibit a larger degree
of uncertainty and a lower degree of separability.
In summary, uncertainty and information asymmetries
give rise to a deeply-rooted supply-side mindset in health
care delivery. The prevailing business models of hospitals
and doctor’s practices emerged from this mindset and
have not radically changed ever since. Standardizability
and separability, along with patient-centeredness, allow for
six new types of business models in addition to the trad-
itional business models of hospitals and doctor’s practices.
These radical changes in business models, more than just
changing payment mechanisms, are more likely to yield
real changes in how health care providers deliver more
value for each dollar spent.
Discussion
General hospitals usually cross-subsidize loss-making ser-
vice lines with profit-making ones, so their sustainability
depends critically on this compensatory scheme in order
to distribute the heavy overhead burden [5]. This is one
argument for hospitals to oppose the separation of service
lines in freestanding facilities, particularly those that are
more profitable.
However, it could be argued that, depending on how pri-
cing is reshaped to reflect actual costs of production, this
complex combination of cross subsidies can be reversed.
Business models focused on highly standardized processes
will be more able to bundle-price their services on a fee-
for-outcome basis, and prices will be more likely to reflect
marginal costs. General hospitals will be more able to
price complex processes on a fee-for-service basis but also
reflecting marginal costs. Therefore, competition will be
more likely to result in higher value for money, just the
way it happens in other markets.
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reshaped into two different business models: one for
highly standardized processes, such as minor ailments,
routine follow-up of patients with chronic non-complex
conditions, immunizations, and screening tests; and one
for those patients that require further study or are more
complex and non-standardized [5]. Standardized pro-
cesses can be delegated to other health care workers
without decreasing quality, and the most expensive and
scarce workforce can be focused on those processes in
which it is strictly necessary [16].
It can be expected that overall health system efficiency
will benefit; hospitals and doctor’s practices will probably
become more expensive, even though their prices reflect
marginal costs. However, the other five business models
will cause prices to decrease as a consequence of a more
market-like competition. The net effect of both changes
would be expected to be positive, i.e., net efficiency gains
for the health system, or put another way, more value for
money as a consequence of value-based competition. How
does it impact equity and poverty? According to Scott et al.
[17], universal coverage to improve access to care by the
poor is not enough. They cite the experience of a condi-
tional cash transfer program in India that improved access
to maternity care and institutional delivery of babies, but
did not improve maternal mortality rates. Therefore, the
goal of universal coverage has to be rephrased to say “uni-
versal access to high-quality care for the poor.” Otherwise
health policies aimed at universal coverage will be futile,
health care will be less affordable and more inequitable,
and health care spending will be more inefficient.
The quick answer to how business model innovations
can improve equity in access to high-quality care is that
a large part of the innovative business models that follow
the lines of this article have emerged mostly in India and
sub-Saharan Africa but also in other developing coun-
tries [18]. Surgery for cataracts and other eye conditions
at Aravind Eye Care System and LV Prasad Eye Institute,
birth attendance and maternity care at Life Spring, heart
surgery and hip replacement at Narayana Hospitals, and
cancer treatment at Health Care Global, are examples of
low-cost high-quality services that are accessible to the
poorest in India. Sala Uno is an application of the Ara-
vind business model in Mexico. Penda Health and One
Family Health are examples of primary care services in
Africa. Medicall, Grand-Aides, and Aprofe are examples
in Latin America and the United States [19]. It is clear
that business model innovations in health care delivery
hold a promise for affordable, high value-for-money so-
lutions for the poorest.
Summary
Innovations in health care delivery models are a necessary
step to evolve towards a more market-like environmentwhere competition among providers leads to more value
for money. The traditional business models of general
hospitals and doctor’s practices are not adequate for every
kind of task, and this explains part of the sustainability
problems of health care systems. New business models are
emerging that shed light on this claim, but they show di-
verse degrees of innovation along the lines of standardiz-
ability and separability, as well as patient centeredness.
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